Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)
Clinical trial NCT07394062 · RECRUITING
Trial details
- NCT number
- NCT07394062
- Sponsor
- Gazi University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-08-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.